Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRT and Etidronate in Glucocorticoid-Induced Osteoporosis
NCT00376662Phase 4Completed
- Sponsor
- British Thoracic Society
- Start
- Aug 1992
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of estradiol valerate + dydrogesterone and etidronate in osteoporosis (4 arms), sponsored by British Thoracic Society. Primary endpoints: New symptomatic fractures at 5 years, New or worsening morphometric fractures of the thoraco-lumbar spine at 5 years and 1 more. Started Aug 1992; status: completed.
02
Drugs
estradiol valerate + dydrogesteroneetidronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00376662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376662.